OvaScience

OvaScience

Employees:
120
Market Cap:
$50.09 million
Revenue:
$826.5 thousand
Net Income:
$-79.84 million
NASDAQ:
OVAS

OvaScience is a publicly traded biotechnology company, focused on female infertility. It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair. Wikipedia

OvaScience

Employees:
120
Market Cap:
$50.09 million
Revenue:
$826.5 thousand
Net Income:
$-79.84 million
NASDAQ:
OVAS

OvaScience is a publicly traded biotechnology company, focused on female infertility. It was founded in 2011 by Michelle Dipp, Richard Aldrich, Christoph Westphal, Jonathan Tilly, and David Sinclair based on scientific work done by Tilly concerning mammalian oogonial stem cells and work on mitochondria by Sinclair. Wikipedia

Jul 17, 5:21 PM

Jul 17, 5:19 PM

Congratulations to Professor Justin St. John Hudson Institute of Medical Research on his presentation about the role of mitochondrial DNA in oocyte competence and embryo development at the Society for the Study of Reproductions 50th Annual Meeting. #SSR2017 http://bit.ly/2uovSGq http://bit.ly/2u1ypDk

Jul 17, 5:05 PM

Jun 22, 8:13 PM

Yesterday we announced Christopher Kroeger, M.D., M.B.A., as our new CEO. Dr. Kroeger earned his B.A. from Harvard University, his M.D. from Stanford University School of Medicine and did his Residency in General Surgery at the Brigham and Womens Hospital, an affiliate of Harvard Medical School. He also holds his M.B.A. from Harvard Business School. Welcome to OvaScience & back to Boston!